Clin-STAR Database
Index
Log in
Search form
Home
People
Institutions
Publications
Grants
Visualizations
FAQ
clin-star.org
Analysis of Overall Survival Benefit of Abemaciclib Plus Fulvestrant in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer.
Overview
Identity
Additional Document Info
View All
Overview
authors
Sun, Ryan
Dae Hyun Kim, MD, MPH, ScD
Wei, Lee-Jen
publication date
January 1, 2020
published in
JAMA oncology
Journal
has subject area
Aminopyridines
Benzimidazoles
Breast Neoplasms
Fulvestrant
Humans
Receptor, ErbB-2
Identity
Digital Object Identifier (DOI)
https://doi.org/10.1001/jamaoncol.2020.1513
PubMed ID
32463424
Additional Document Info
start page
1121
end page
1122
volume
6
issue
7